Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL (Q65394920)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL |
clinical trial |
Statements
Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma (English)
0 references
26 August 2016
0 references
26 October 2021
0 references
40
0 references
3 year
0 references